SMTL ID : 4aa5.1

P38ALPHA MAP KINASE BOUND TO CMPD 33

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.38 Å

Oligo State

monomer

Ligands

1 x NQB: N-CYCLOPROPYL-4-METHYL-3-[6-(4-METHYLPIPERAZIN-1-YL)-4-OXIDANYLIDENE-QUINAZOLIN-3-YL]BENZAMIDE(Non-covalent)

NQB.1: 15 residues within 4Å: Chain A: V.35, S.37, G.38, V.43, A.56, K.58, E.76, L.79, L.80, I.89, L.109, T.111, L.172, D.173, F.174 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:V.43, A:A.56, A:K.58, A:E.76, A:L.79, A:L.80, A:L.80, A:T.111, A:L.172, A:F.174, A:F.174 Hydrogen bonds: A:E.76, A:E.76, A:T.111, A:D.173 Water bridges: A:A.39, A:K.58 pi-Cation interactions: A:K.58

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Brown, D.S. et al., The Discovery of N-Cyclopropyl-4-Methyl-3-[6--(4-Methylpiperazin-1-Yl-4-Oxoquinazolin-3(4H)-Yl]Benzamide (Azd6703), a Clinical P38Alpha Map Kinase Inhibitor for the Treatment of Inflammatory Diseases. Bioorg.Med.Chem.Lett. (2012)

Release Date

2012-05-16

Peptides

MITOGEN-ACTIVATED PROTEIN KINASE 14: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

MITOGEN-ACTIVATED PROTEIN KINASE 14

Related Entries With Identical Sequence